Skip to main content
Clinical Trials/NCT04120077
NCT04120077
Unknown
Not Applicable

KNOC OUT DIABETES: Combined Effects of Diabetes Self-Management Education and Nutritional Supplementation on Visual Function and Retinopathy

ZeaVision, LLC1 site in 1 country150 target enrollmentJanuary 1, 2020

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Diabetes Mellitus
Sponsor
ZeaVision, LLC
Enrollment
150
Locations
1
Primary Endpoint
full-field flicker electroretinogram (ffERG) amplitude (microvolts)
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the combined effects of diabetes self-management education (DSME) and nutritional supplementation on visual function and retinopathy incidence & progression in patients with type 1 diabetes, type 2 diabetes and pre-diabetes.

Detailed Description

This will be an investigator initiated, multi-center, double-blinded prospective study of 150-200 adult subjects with established prediabetes or diabetes. Subjects will be identified and enrolled with informed consent from 4 private optometric practices in the Southeastern and Central United States. Enrollment in the diabetes self-management education (DSME) component of the study will be requisite for participation in the trial and DSME will be provided by designated study investigators trained to deliver AADE7™ curricula in individual and/or group settings. Subjects will be randomized to DSME in isolation or in combination with one of two nutritional supplementation arms of the trial (described below). Supplements will be provided by ZeaVision, LLC of Chesterfield, MO. Subjects will undergo initial KNOC out Diabetes™ visits with assessment of current diabetes status and provision of DSME curriculum, with follow-up DSME assessments and goal reporting at 1-month, 3-months, 6-months, 9-months and 12-months. Subjects will receive comprehensive dilated eye examinations with additional tests of visual function (described below) at baseline, 3 months, 6 months and 12 months. KNOC out Diabetes™ is a 10-session, diabetes self-management education program designed to improve patient behaviors and blood glucose over a 12 month period and delivered by doctors of optometry. KNOC is an acronym for "Knowledge, Nutrition, Ocular Health and Coaching. The program features weekly internet learning, experiential learning focused on solving specific, individualized patient diabetes management problems, weekly phone coaching Test nutritional supplements will be: (1) a multi-component formula (EyePromise DVS™) (2) a high-potency marine-sourced omega-3 polyunsaturated fatty acid supplement (EyePromise EZTears™).

Registry
clinicaltrials.gov
Start Date
January 1, 2020
End Date
January 1, 2022
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • diagnosed prediabetes, type 1 or type 2 diabetes
  • no diabetic retinopathy (DR), mild DR or moderate DR without center-involved macular edema
  • age \> 18 years
  • ability to give informed consent
  • best corrected visual acuity \> 20/30 in each eye.

Exclusion Criteria

  • no formal diagnosis of prediabetes or diabetes
  • age \< 18 years
  • inability to give informed consent
  • best corrected visual acuity \< 20/30 in either eye
  • center-involved DME by spectral domain optical coherence tomography \* evidence of severe non-proliferative or proliferative diabetic retinopathy
  • evidence of other serious ocular disease (age-related macular degeneration, glaucoma, significant media opacity)
  • history of intraocular surgery, including macular or panretinal photocoagulation or prior intra-ocular injection of anti-Vascular endothelial growth factor (anti-VEGF) drugs (except uncomplicated cataract or keratorefractive surgery more than 6 months prior to enrollment)
  • pregnant and nursing women
  • known sensitivity to any of the supplement ingredients.

Outcomes

Primary Outcomes

full-field flicker electroretinogram (ffERG) amplitude (microvolts)

Time Frame: Change from baseline to 12 months

The Flicker ERG will be recorded using a commercially available system, (RetEval, Konan Medical, Irvine, CA). The test will be performed in an illuminated room, free of visual and audible distractions. Subjects will be instructed to fixate on a target using the fellow eye (eye not been tested) and results will be consecutively recorded from both eyes by means of skin electrodes

glycosylated hemoglobin (HbA1c) percentage

Time Frame: Change from baseline to 12 months

HbA1c is a measure of mean blood glucose over a 8-12 week duration and requires a simple fingerstick blood draw.

full-field flicker electroretinogram (ffERG) implicit time (milliseconds)

Time Frame: Change from baseline to 12 months

The Flicker ERG will be recorded using a commercially available system, (RetEval, Konan Medical, Irvine, CA). The test will be performed in an illuminated room, free of visual and audible distractions. Subjects will be instructed to fixate on a target using the fellow eye (eye not been tested) and results will be consecutively recorded from both eyes by means of skin electrodes

Secondary Outcomes

  • Diabetic Retinopathy Severity using International Diabetic Retinopathy Severity Scale (DRSS)(Change comparing Baseline to 12 months)
  • Color Contrast Threshold Sensitivity (minimal percentage contrast detection for each pre-specified wavelength)(Change comparing Baseline and 12 months)
  • Ocular Surface Disease Index Score (OSDI)(Change comparing Baseline score and score at 12 months)
  • body mass index (BMI) Kg/meter(squared)(Change comparing Baseline to 12 months)

Study Sites (1)

Loading locations...

Similar Trials